Pyridoxal Phosphate Anhydrous

Pyridoxal Phosphate Anhydrous

SCHEMBL20335524

Cc1ncc(COP(=O)(O)O)c(C=O)c1O.[Cu]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX2 Q9UBL9 3/20 0.97
▸ ESR1 P03372 1/20 0.97
▸ PTGS1 P23219 1/20 0.97
▸ ACP1 P24666 1/20 0.97
▸ PDE4A P27815 1/20 0.97
▸ P2RX1 P51575 1/20 0.97
▸ KDM4E B2RXH2 3/20 0.60
▸ MEN1 O00255 2/20 0.60
▸ ALDH1A1 P00352 2/20 0.60
▸ HPGD P15428 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ PNPO Q9NVS9 1/20 0.60
▸ LMNA P02545 1/20 0.60
▸ AOX1 Q06278 1/20 0.60
▸ TRIM24 O15164 1/20 0.58
▸ TRIM33 Q9UPN9 1/20 0.58
▸ P2RX7 Q99572 2/20 0.44
▸ YWHAG P61981 1/20 0.44
▸ YWHAZ P63104 1/20 0.44
▸ PDXK O00764 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridoxal Phosphate Anhydrous SCHEMBL29362986 0.99 P2RX2 (1.00) P2RX2ESR1PTGS1ACP1PDE4A
Pyridoxal Phosphate Anhydrous SCHEMBL23158 0.99 P2RX2 (1.00) P2RX2ESR1PTGS1ACP1PDE4A
Pyridoxal Phosphate Anhydrous SCHEMBL4916108 0.97 P2RX2 (0.97) P2RX2ESR1PTGS1ACP1PDE4A
Pyridoxal Phosphate Anhydrous SCHEMBL29392551 0.97 P2RX2 (0.97) P2RX2ESR1PTGS1ACP1PDE4A
Pyridoxal Phosphate Anhydrous SCHEMBL827100 0.97 P2RX2 (0.97) P2RX2ESR1PTGS1ACP1PDE4A
Pyridoxal Phosphate Anhydrous SCHEMBL20335516 0.97 P2RX2 (0.97) P2RX2ESR1PTGS1ACP1PDE4A
Pyridoxal Phosphate Anhydrous SCHEMBL2746592 0.97 P2RX2 (0.97) P2RX2ESR1PTGS1ACP1PDE4A
Pyridoxal Phosphate Anhydrous SCHEMBL28200961 0.93 ESR1 (0.90) P2RX2ESR1PTGS1ACP1PDE4A
Pyridoxal Phosphate Anhydrous SCHEMBL29424718 0.92 P2RX2 (0.88) P2RX2ESR1PTGS1ACP1PDE4A
Pyridoxal Phosphate Anhydrous SCHEMBL10534222 0.92 P2RX2 (0.88) P2RX2ESR1PTGS1ACP1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026104886-A1 METHOD FOR EXTRACTING LOW-MOLECULAR WEIGHT COLLAGEN USING POLLACK SKIN, LOW-MOLECULAR WEIGHT COLLAGEN, AND COSMETIC COMPOSITION COMPRISING SAME WITH SKIN REGENERATION EFFICACY 유엔케이코리아 주식회사 2026-05-21 — — WO disclosed
US-12350352-B2 Composition for surface modification LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2025-07-08 — — US disclosed
EP-3342395-B1 COMPOSITION FOR HAIR SURFACE MODIFICATION LG HOUSEHOLD & HEALTH CARE LTD (KR) 2024-08-07 — — EP disclosed
EP-4406617-A2 COMPOSITION FOR SURFACE MODIFICATION LG Household & Health Care Ltd. (KR) 2024-07-31 — — EP disclosed
US-11612552-B2 Composition for surface modification LG HOUSEHOLD & HEALTH CARE LTD. 2023-03-28 — — US disclosed
US-20230088314-A1 Composition For Surface Modification LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2023-03-23 — — US disclosed
WO-2022114681-A1 CLEANSER COMPOSITION WITH ENHANCED ACTIVE SUBSTANCE DELIVERY 주식회사 엘지생활건강 2022-06-02 — — WO disclosed
US-20200345599-A1 Composition For Surface Modification LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2020-11-05 — — US disclosed
US-10799436-B2 Composition for surface modification LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2020-10-13 — — US disclosed
US-20180193236-A1 COMPOSITION FOR SURFACE MODIFICATION LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2018-07-12 — — US disclosed
EP-3342395-A2 COMPOSITION FOR SURFACE MODIFICATION LG Household & Health Care Ltd. (KR) 2018-07-04 — — EP disclosed
CN-107920973-A Surface composition for modifying 株式会社LG生活健康 2018-04-17 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12350352-B2 Composition for surface modification CUTA, PTMS, DNMT1 P2RX2 3849/4885ESR1 4072/4885PTGS1 2945/4885
US-20230088314-A1 Composition For Surface Modification CUTA, PTMS, DNMT1 P2RX2 3849/4885ESR1 4072/4885PTGS1 2945/4885
US-11612552-B2 Composition for surface modification CUTA, PTMS, DNMT1 P2RX2 3849/4885ESR1 4072/4885PTGS1 2945/4885
US-10799436-B2 Composition for surface modification CUTA, PTMS, DNMT1 P2RX2 3849/4885ESR1 4072/4885PTGS1 2945/4885
US-20180193236-A1 COMPOSITION FOR SURFACE MODIFICATION CUTA, PTMS, DNMT1 P2RX2 3849/4885ESR1 4072/4885PTGS1 2945/4885
US-20200345599-A1 Composition For Surface Modification CUTA, PTMS, DNMT1 P2RX2 3849/4885ESR1 4072/4885PTGS1 2945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback